The International Prostate Symptom Score (IPSS) is a scoring system used to screen for and diagnose benign prostatic hyperplasia (BPH) as well as to monitor symptoms and guide decisions about how ...

Most men over 50 will develop an enlarged prostate. Also called benign prostatic hyperplasia (BPH), this bothersome condition ...

The studies, which included 72 participants, utilised IPSS and IPSS-QOL to measure symptom improvement.

Presentations at the 37th Annual European Association of Urology Congress to Demonstrate Measurable and Sustained Improvement of BPH Symptoms and IPSS Scores WAYNE, Pa., July 01, 2022 (GLOBE ...

The IPSS is a symptom score for use in men with LUTS secondary to benign prostatic hyperplasia (BPH). The score consists of two parts. The first features seven questions regarding the severity of a ...

Non-Ablative Intervention for BPH/LUTS Reduces Symptoms With Low Retreatment Rate — Urinary flow, IPSS improved by 50-60% with Optilume device over 5 years with one re-operation ...

Improvement in International Prostate Symptom Score (IPSS) from baseline to the stated time point in the intent-to-treat population (mean±95% CI). Credit: Journal of Urology (2023).

The men were assessed for symptoms of prostate disease by answering questions on the International-Prostate Symptom Score (IPSS) test about their quality of life and possible urination issues.

Investigators analyzed OABSS and IPSS scores from Japanese patients with lower urinary tract symptoms for seasonal differences.

Aquablation is a newer treatment that may effectively treat urinary symptoms of benign prostatic hyperplasia. Medicare covers it in some cases.

Baseline symptom scores decreased by 11-12 points at 3 months with aquablation and transurethral laser enucleation of the prostate (LEP).